SNORD87: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Target Name: SNORD87

NCBI ID: G641648

SNORD87

SNORD87: A Potential Drug Target and Biomarker for Small Nucleolar RNA

Small nucleolar RNA (snRNA) is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression in eukaryotic cells. One of the key functions of snRNA is to help maintain the stability of chromatin by base pairing with specific DNA sequences . In addition to this function, snRNA has also been shown to play a key role in the regulation of RNA stability and localization to specific cellular structures.

One of the unique features of snRNA is its ability to interact with other molecules, including proteins and small molecules. This interactivity makes snRNA a potentially interesting drug target and biomarker. In this article, we will discuss the potential of SNORD87 as a drug target and biomarker for small nucleolar RNA.

SNORD87 as a Drug Target

SNORD87 is a 22-nt RNA molecule that contains a characteristic C/D box structure. This structure consists of a conserved core region that is rich in secondary structure, as well as a 5' and 3' end that are highly conserved in sequence. The 5' end of SNORD87 contains a single AUG codon, which is the starting point for protein synthesis. The 3' end of SNORD87 contains a GGU codon, which is also a starting point for protein synthesis.

SNORD87 has been shown to play a role in the regulation of gene expression in various cellular processes. One of the key functions of SNORD87 is to act as a scaffold to recruit other proteins to the site of gene expression. This can be done through its conserved C/D box structure, which allows it to interact with other molecules in a specific way.

SNORD87 has also been shown to play a role in the regulation of RNA stability and localization to specific cellular structures. This can be done through its ability to interact with other molecules, including proteins that are involved in the regulation of chromatin structure and stability.

SNORD87 as a Biomarker

SNORD87 has also been shown to be a potential biomarker for various diseases. For example, SNORD87 has been shown to be downregulated in various cancer cells, which suggests that it may have a potential role in the regulation of cancer growth.

SNORD87 has also been shown to be involved in the regulation of cellular processes that are important for human health, such as the regulation of immune responses and the regulation of inflammation. This suggests that SNORD87 may have a potential role in the treatment of various diseases.

Conclusion

In conclusion, SNORD87 is a 22-nt RNA molecule that has been shown to play a crucial role in the regulation of gene expression in eukaryotic cells. Its conserved C/D box structure and ability to interact with other molecules make it a potentially interesting drug target and biomarker. Further research is needed to fully understand the functions of SNORD87 in the regulation of gene expression and cellular processes.

Protein Name: Small Nucleolar RNA, C/D Box 87

The "SNORD87 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD87 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets